Neuropathic Orofacial Pain

https://doi.org/10.1016/j.cden.2018.05.005Get rights and content

Section snippets

Key points

  • Neuropathic orofacial pain is described as a pain caused by a lesion or disease of the somatosensory nervous system.

  • Nociceptive stimuli in the orofacial region is modulated as it ascends to the thalamus and then to the somatosensory areas of the cortex.

  • Complexities in individual pain perceptions are due to the influence of cognitive, affective, and motivational factors.

  • Research continues to be undertaken to introduce more effective management options for neuropathic orofacial pain patients.

Trigeminal neuralgia

Trigeminal neuralgia (TN) is a paroxysmal, unilateral, short-lasting facial pain. Onset of TN may be abrupt or through a rarer preceding syndrome termed pre-TN.

Glossopharyngeal neuralgia

Glossopharyngeal neuralgia (GPN) is a severe, transient (fraction of a second to 2 minute), stabbing pain experienced in the ear, base of the tongue, tonsillar fossa, or beneath the angle of the jaw.34 Pain is usually unilateral, but up to 25% of patients may experience bilateral pain.35

The overall incidence is estimated to be between 0.2 and 0.7 per 100,000 individuals per year.35 GPN occurs in adults, with a predilection for women and for patients over the age of 50.36

GPN may be divided into

Nervus intermedius (facial nerve/geniculate neuralgia)

Nervus intermedius neuralgia is described as a severe, short-lasting pain in the auditory canal in the absence of other pathologic condition.34 Nervus intermedius neuralgia is rare. Middle-aged adults seem to be predominantly affected, women more than men.45

Superior laryngeal neuralgia

Superior laryngeal neuralgia is a rare disorder, with short-lasting pain, localized predominantly to one side of the laryngeal region and occasionally radiating to the lower lateral jaw or ear49:

  • Paroxysmal pain

  • Lancinating pain

  • May be triggered by pressure to the skin above and lateral to the thyroid cartilage where the internal branch of the superior laryngeal nerve pierces the thyrohyoid membrane

Peripheral neuritis

Neuritis is a localized neural pathologic condition resulting from inflammation.

Herpes zoster and postherpetic neuralgia

Herpes zoster (HZ) results from the reactivation of the varicella zoster virus (VZV) within the cranial sensory ganglia. This viral reactivation leads to acute inflammatory changes within the ganglion of the affected dermatome but also extends peripherally along the length of the sensory nerve (neuritis), followed by neuronal destruction.61 These inflammatory changes and neural damage results in a painful vesicular rash in the associated unilateral dermatome.

HZ has a prodrome of less than a

Persistent idiopathic facial pain

Persistent idiopathic facial pain (PIFP) refers to persistent extraoral and/or intraoral pain along the territory of the trigeminal nerve that does not fit the classic presentation of other cranial neuralgias or another disorder.80 PIFP is mainly seen in adult women with a prevalence of 0.03 to 1.0%.80

Peripheral painful traumatic trigeminal neuropathy

Peripheral painful traumatic trigeminal neuropathy is defined as a spontaneous or stimulus-dependent pain or disturbed sensation, predominately affecting the receptive field of one or more divisions of the trigeminal nerve.

There is a combination of environmental (reduced social support),89 psychosocial (anxious, introverted personalities),89 and genetic factors (polymorphism in the gene encoding serotonin transporter),72, 89 which may vary an individual’s pain experience.

Summary

Further research is required to further the knowledge of neuropathic orofacial pain conditions as well as their management.

Newer therapies are currently being tested, such as novel cellular/molecular therapies, for neuropathic orofacial pain disorders, including local injection of autologous mesenchymal stem cells,93 regulation of satellite glial cells,94 and delivery of substance P,95 endomorphin,96 and cannabinoids.97

Well-constructed trials are required to introduce more effective management

First page preview

First page preview
Click to open first page preview

References (97)

  • M.R. Amin et al.

    Vagal neuropathy after upper respiratory infection: a viral etiology?

    Am J Otolaryngol

    (2001)
  • S. Kodama et al.

    Superior laryngeal neuralgia associated with deviation of the hyoid bone

    Auris Nasus Larynx

    (2008)
  • E. Eliav et al.

    Facial arthralgia and myalgia: can they be differentiated by trigeminal sensory assessment?

    Pain

    (2003)
  • E. Eliav et al.

    Large myelinated nerve fiber hypersensitivity in oral malignancy

    Oral Surg Oral Med Oral Pathol Oral Radiol Endod

    (2002)
  • C.P. Watson et al.

    Post-herpetic neuralgia: further post-mortem studies of cases with and without pain

    Pain

    (1991)
  • G. Heir et al.

    Use of topical medication in orofacial neuropathic pain: a retrospective study

    Oral Surg Oral Med Oral Pathol Oral Radiol Endod

    (2008)
  • J. Zakrzewska

    Chronic/persistent idiopathic facial pain

    Neurosurg Clin N Am

    (2016)
  • E. Lang et al.

    Persistent idiopathic facial pain exists independent of somatosensory input from the painful region: findings from quantitative sensory functions and somatotopy of the primary somatosensory cortex

    Pain

    (2005)
  • C. Feinmann

    The long-term outcome of facial pain treatment

    J Psychosom Res

    (1993)
  • S. Morley et al.

    Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache

    Pain

    (1999)
  • N. Finnerup et al.

    The evidence of pharmacological treatment of neuropathic pain

    Pain

    (2010)
  • G. Mustafa et al.

    Anti-nociceptive effect of a conjugate of substance P and light chain of botulinum neurotoxin type A

    Pain

    (2013)
  • W. Makuch et al.

    Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats

    Neuropharmacology

    (2013)
  • E.J. Rahn et al.

    Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside

    Neurotherapeutics

    (2009)
  • G.H. Fromm et al.

    Pre-trigeminal neuralgia

    Neurology

    (1990)
  • A. Puca et al.

    Evaluation of fifth nerve dysfunction in 136 patients with middle and posterior cranial fossae tumors

    Eur Neurol

    (1995)
  • R. De Simone et al.

    A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis

    Neurol Sci

    (2005)
  • E.C. Tyler-Kabara et al.

    Predictors of outcome in surgically managed patients with typical and atypical trigeminal neuralgia: comparison of results following microvascular decompression

    J Neurosurg

    (2002)
  • M. Devor et al.

    Pathophysiology of trigeminal neuralgia: the ignition hypothesis

    Clin J Pain

    (2002)
  • T. Jorns et al.

    Evidence based approach to the medical management of trigeminal neuralgia

    Br J Neurosurg

    (2007)
  • G. Fromm et al.

    Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up

    Ann Neurol

    (1984)
  • M. Obermann et al.

    Efficacy of pregabalin in the treatment of trigeminal neuralgia

    Cephalalgia

    (2008)
  • M. Zvartau-Hind et al.

    Topiramate relieves refractory trigeminal neuralgia in MS patients

    Neurology

    (2000)
  • A. Kanai et al.

    Subcutaneous sumatriptan for refractory trigeminal neuralgia

    Headache

    (2006)
  • M. Morra et al.

    Therapeutic efficacy and safety of botulinum toxin A therapy in trigeminal neuralgia: a systematic review and meta-analysis of randomized controlled trials

    J Headache Pain

    (2016)
  • G. Verma

    Role of botulinum toxin type-A (BTX-A) in the management of trigeminal neuralgia

    Pain Res Treat

    (2013)
  • C. Oesman et al.

    Long-term follow-up of microvascular decompression for trigeminal neuralgia

    Skull Base

    (2011)
  • Z. Sarsam et al.

    The long-term outcome of microvascular decompression for trigeminal neuralgia

    Br J Neurosurg

    (2010)
  • R. Rey-Dios et al.

    Current neurosurgical management of glossopharyngeal neuralgia and technical nuances for microvascular decompression surgery

    Neurosurg Focus

    (2013)
  • T.J. Lovely et al.

    Surgical management of geniculate neuralgia

    Am J Otol

    (1997)
  • M. Nanjappa et al.

    Percutaneous radiofrequency rhizotomy in treatment of trigeminal neuralgia: a prospective study

    J Maxillofac Oral Surg

    (2013)
  • C. Alafaci et al.

    Glossopharyngeal neuralgia caused by a complex neurovascular conflict: case report and review of the literature

    Surg Neurol Int

    (2015)
  • V. Rupa et al.

    Geniculate neuralgia: the surgical management of primary otalgia

    J Neurosurg

    (1991)
  • Q. Zong et al.

    Rhizotomy targeting the intermediate nerve, the glossopharyngeal nerve and the upper 1st to 2nd rootlets of the vagus nerve for the treatment of laryngeal neuralgia combined with intermediate nerve neuralgia-a case report

    BMC Surg

    (2014)
  • K. Kouzounias et al.

    Factors that influence outcome of percutaneous balloon compression in the treatment of trigeminal neuralgia

    Neurosurgery

    (2010)
  • Y. Kanpolat et al.

    Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1,600 patients

    Neurosurgery

    (2001)
  • X. Wang et al.

    Long-term outcomes of percutaneous radiofrequency thermocoagulation for glossopharyngeal neuralgia A retrospective observational study

    Medicine (Baltimore)

    (2016)
  • B. Lopez et al.

    Stereotactic radiosurgery for primary trigeminal neuralgia: state of the evidence and recommendation for future reports

    J Neurol Neurosurg Psychiatry

    (2004)
  • Cited by (0)

    Disclosure Statement: The author has nothing to disclose.

    View full text